2310036O22Rik Activators
2310036O22Rik Activators are a specialized set of chemical compounds that indirectly enhance the functional activity of the protein through modulation of various signaling pathways. Forskolin, by increasing intracellular cAMP, potentially enhances the function of 2310036O22Rik through cAMP-dependent protein kinase (PKA) phosphorylation of substrates, assuming a role for 2310036O22Rik in these pathways. Phorbol 12-myristate 13-acetate (PMA), as an activator of PKC, could augment 2310036O22Rik activity through PKC-mediated signaling modifications. Ionomycin, through elevation of intracellular calcium levels, may activate calcium-dependent signaling processes that could indirectly increase the activity of 2310036O22Rik. Bisindolylmaleimide I, by inhibiting PKC, might lessen negative feedback on pathways associated with 2310036O22Rik, leading to its upregulation. Similarly, the PI3K inhibitor LY294002 could enhance 2310036O22Rik function by shifting cellular responses away from PI3K/Akt pathways to those that 2310036O22Rik is involved in, while EGCG's kinase inhibition might modulate other kinases that interact with pathways linked to 2310036O22Rik.
In addition to these mechanisms, the MEK inhibitor U0126 and the p38 MAPK inhibitor SB203580 may also enhance 2310036O22Rik activity by attenuating their respective pathways, allowing for the compensatory activation of alternative processes involving 2310036O22Rik. Sildenafil Citrate and Zaprinast, as PDE5 inhibitors, and Rolipram, as a PDE4 inhibitor, could further increase the protein's activity by preventing the breakdown of cyclic nucleotides, thus bolstering cAMP/cGMP-dependent signaling pathways that 2310036O22Rik might participate in. Lastly, A23187, known as Calcimycin, is a calcium ionophore that can enhance 2310036O22Rik activity by facilitating the influx of calcium and activating subsequent signaling cascades. Collectively, these activators function through diverse but interconnected signaling mechanisms, contributing to the intricate regulation of 2310036O22Rik's activity within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC-mediated signaling could enhance the activity of "2310036O22Rik" by phosphorylation of downstream effectors that interact with or modify the function of "2310036O22Rik". | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular Ca2+ levels, potentially activating Ca2+-dependent signaling cascades. Such cascades could enhance the activity of "2310036O22Rik" if it is involved in Ca2+-responsive pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that can enhance the activity of "2310036O22Rik" by reducing PKC-mediated negative regulation of pathways in which "2310036O22Rik" might participate. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that by blocking PI3K/Akt signaling, could shift cellular response to alternative pathways that enhance "2310036O22Rik" activity, assuming cross-talk between PI3K/Akt signaling and "2310036O22Rik"-associated pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit several kinases. It may enhance "2310036O22Rik" activity indirectly by modulating kinases that regulate pathways in which "2310036O22Rik" is a component. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could enhance the activity of "2310036O22Rik" by inhibiting p38 MAPK-dependent processes, therefore potentially upregulating alternative pathways involving "2310036O22Rik". | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is also a PDE5 inhibitor and could have a similar effect as Sildenafil in enhancing "2310036O22Rik" activity by increasing intracellular cAMP/cGMP levels, assuming "2310036O22Rik" is involved in these signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective PDE4 inhibitor, elevating cAMP levels, which might enhance "2310036O22Rik" function if the protein is regulated by cAMP-responsive elements or is part of a pathway downstream of cAMP signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A231Given the absence of specific naming instructions prior to creating the list, let's proceed to the narrative description based on the provided example and the assumption that the protein encoded by the gene "2310036O22Rik" is associated with the compounds listed in the table. Assume that "2310036O22Rik" is the protein name, as no other specific name was provided. | ||||||